This pipeline uses various statistical tests to identify selected clinical features related to APOBEC signature variables.
Testing the association between 3 variables and 17 clinical features across 100 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 4 clinical features related to at least one variables.
-
1 variable correlated to 'HISTOLOGICAL_TYPE'.
-
[TCW_TO_G+TCW_TO_T]_PER_MUT
-
1 variable correlated to 'MSI'.
-
[TCW_TO_G+TCW_TO_T]_PER_MUT
-
1 variable correlated to 'RACE'.
-
[TCW_TO_G+TCW_TO_T]_PER_MUT
-
2 variables correlated to 'BMI'.
-
[TCW_TO_G+TCW_TO_T]_PER_MUT , TCW_TO_G+TCW_TO_T
-
No variables correlated to 'DAYS_TO_DEATH_OR_LAST_FUP', 'FIGO_GRADE', 'KARNOFSKY_PERFORMANCE_SCORE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGIC_STAGE', 'YEARS_TO_BIRTH', 'ETHNICITY', 'RADIATION_THERAPY', 'DIABETES', 'NUMBER_PACK_YEARS_SMOKED', 'SMOKER', and 'COUNTRY_OF_ORIGIN'.
Complete statistical result table is provided in Supplement Table 1
Table 1. Get Full Table This table shows the clinical features, statistical methods used, and the number of variables that are significantly associated with each clinical feature at P value < 0.05 and Q value < 0.3.
Clinical feature | Statistical test | Significant variables | Associated with | Associated with | ||
---|---|---|---|---|---|---|
DAYS_TO_DEATH_OR_LAST_FUP | Cox regression test | N=0 | ||||
HISTOLOGICAL_TYPE | Kruskal-Wallis test | N=1 | ||||
FIGO_GRADE | Kruskal-Wallis test | N=0 | ||||
KARNOFSKY_PERFORMANCE_SCORE | Spearman correlation test | N=0 | ||||
MSI | Kruskal-Wallis test | N=1 | ||||
PATHOLOGY_T_STAGE | Spearman correlation test | N=0 | ||||
PATHOLOGY_N_STAGE | Spearman correlation test | N=0 | ||||
PATHOLOGIC_STAGE | Kruskal-Wallis test | N=0 | ||||
YEARS_TO_BIRTH | Spearman correlation test | N=0 | ||||
ETHNICITY | Wilcoxon test | N=0 | ||||
RACE | Kruskal-Wallis test | N=1 | ||||
RADIATION_THERAPY | Wilcoxon test | N=0 | ||||
DIABETES | Wilcoxon test | N=0 | ||||
BMI | Kruskal-Wallis test | N=2 | ||||
NUMBER_PACK_YEARS_SMOKED | Spearman correlation test | N=0 | ||||
SMOKER | Wilcoxon test | N=0 | ||||
COUNTRY_OF_ORIGIN | Kruskal-Wallis test | N=0 |
No variable related to 'DAYS_TO_DEATH_OR_LAST_FUP'.
Table S1. Basic characteristics of clinical feature: 'DAYS_TO_DEATH_OR_LAST_FUP'
DAYS_TO_DEATH_OR_LAST_FUP | Duration (Months) | 0-130.4 (median=11.6) |
censored | N = 95 | |
death | N = 3 | |
Significant markers | N = 0 |
Table S2. Basic characteristics of clinical feature: 'HISTOLOGICAL_TYPE'
HISTOLOGICAL_TYPE | Labels | N |
CLEAR CELL CARCINOMA | 1 | |
ENDOMETRIOID CARCINOMA | 77 | |
MIXED CELL ADENOCARCINOMA | 1 | |
SEROUS CARCINOMA | 21 | |
Significant variables | N = 1 |
Table S3. Get Full Table List of one variable differentially expressed by 'HISTOLOGICAL_TYPE'
kruskal_wallis_P | Q | |
---|---|---|
[TCW_TO_G+TCW_TO_T]_PER_MUT | 0.02162 | 0.0648 |
Table S4. Basic characteristics of clinical feature: 'FIGO_GRADE'
FIGO_GRADE | Labels | N |
FIGO GRADE 1 | 32 | |
FIGO GRADE 2 | 34 | |
FIGO GRADE 3 | 7 | |
Significant variables | N = 0 |
No variable related to 'KARNOFSKY_PERFORMANCE_SCORE'.
Table S5. Basic characteristics of clinical feature: 'KARNOFSKY_PERFORMANCE_SCORE'
KARNOFSKY_PERFORMANCE_SCORE | Mean (SD) | 91.9 (8.5) |
Score | N | |
60 | 1 | |
70 | 3 | |
80 | 1 | |
90 | 32 | |
100 | 21 | |
Significant variables | N = 0 |
Table S6. Basic characteristics of clinical feature: 'MSI'
MSI | Labels | N |
MSI-H | 4 | |
MSI-L | 5 | |
MSS | 23 | |
Significant variables | N = 1 |
Table S7. Get Full Table List of one variable differentially expressed by 'MSI'
kruskal_wallis_P | Q | |
---|---|---|
[TCW_TO_G+TCW_TO_T]_PER_MUT | 0.001105 | 0.00332 |
Table S8. Basic characteristics of clinical feature: 'PATHOLOGY_T_STAGE'
PATHOLOGY_T_STAGE | Mean (SD) | 1.31 (0.65) |
N | ||
T1 | 78 | |
T2 | 11 | |
T3 | 10 | |
Significant variables | N = 0 |
Table S9. Basic characteristics of clinical feature: 'PATHOLOGY_N_STAGE'
PATHOLOGY_N_STAGE | Mean (SD) | 0.22 (0.53) |
N | ||
N0 | 46 | |
N1 | 6 | |
N2 | 3 | |
Significant variables | N = 0 |
Table S10. Basic characteristics of clinical feature: 'PATHOLOGIC_STAGE'
PATHOLOGIC_STAGE | Labels | N |
STAGE I | 72 | |
STAGE IA | 1 | |
STAGE IB | 1 | |
STAGE II | 8 | |
STAGE III | 15 | |
STAGE IV | 2 | |
STAGE IVB | 1 | |
Significant variables | N = 0 |
Table S11. Basic characteristics of clinical feature: 'YEARS_TO_BIRTH'
YEARS_TO_BIRTH | Mean (SD) | 63.56 (10) |
Significant variables | N = 0 |
Table S12. Basic characteristics of clinical feature: 'ETHNICITY'
ETHNICITY | Labels | N |
HISPANIC OR LATINO | 4 | |
NOT HISPANIC OR LATINO | 41 | |
Significant variables | N = 0 |
Table S13. Basic characteristics of clinical feature: 'RACE'
RACE | Labels | N |
ASIAN | 1 | |
BLACK OR AFRICAN AMERICAN | 3 | |
WHITE | 58 | |
Significant variables | N = 1 |
Table S14. Get Full Table List of one variable differentially expressed by 'RACE'
kruskal_wallis_P | Q | |
---|---|---|
[TCW_TO_G+TCW_TO_T]_PER_MUT | 0.03614 | 0.108 |
Table S15. Basic characteristics of clinical feature: 'RADIATION_THERAPY'
RADIATION_THERAPY | Labels | N |
NO | 43 | |
YES | 54 | |
Significant variables | N = 0 |
Table S16. Basic characteristics of clinical feature: 'DIABETES'
DIABETES | Labels | N |
NO | 70 | |
YES | 28 | |
Significant variables | N = 0 |
Table S17. Basic characteristics of clinical feature: 'BMI'
BMI | Labels | N |
NORMAL | 8 | |
OBESE | 47 | |
OVERWEIGHT | 21 | |
SEVERELY OBESE | 21 | |
UNDERWEIGHT | 3 | |
Significant variables | N = 2 |
Table S18. Get Full Table List of 2 variables differentially expressed by 'BMI'
kruskal_wallis_P | Q | |
---|---|---|
[TCW_TO_G+TCW_TO_T]_PER_MUT | 0.004533 | 0.0136 |
TCW_TO_G+TCW_TO_T | 0.03504 | 0.0526 |
No variable related to 'NUMBER_PACK_YEARS_SMOKED'.
Table S19. Basic characteristics of clinical feature: 'NUMBER_PACK_YEARS_SMOKED'
NUMBER_PACK_YEARS_SMOKED | Mean (SD) | 14.48 (12) |
Significant variables | N = 0 |
Table S20. Basic characteristics of clinical feature: 'SMOKER'
SMOKER | Labels | N |
NON-SMOKER | 73 | |
SMOKER | 22 | |
Significant variables | N = 0 |
-
Expresson data file = APOBEC_for_clinical.correlaion.input.continuous.txt
-
Clinical data file = CPTAC3-UCEC-TP.clin.merged.picked.txt
-
Number of patients = 100
-
Number of variables = 3
-
Number of clinical features = 17
-
Further details on clinical features selected for this analysis, please find a documentation on selected CDEs (Clinical Data Elements). The first column of the file is a formula to convert values and the second column is a clinical parameter name.
-
There are also useful links about clinical features.
-
Survival time data
-
Survival time data is a combined value of days_to_death and days_to_last_followup. For each patient, it creates a combined value 'days_to_death_or_last_fup' using conversion process below.
-
if 'vital_status'==1(dead), 'days_to_last_followup' is always NA. Thus, uses 'days_to_death' value for 'days_to_death_or_fup'
-
if 'vital_status'==0(alive),
-
if 'days_to_death'==NA & 'days_to_last_followup'!=NA, uses 'days_to_last_followup' value for 'days_to_death_or_fup'
-
if 'days_to_death'!=NA, excludes this case in survival analysis and report the case.
-
if 'vital_status'==NA,excludes this case in survival analysis and report the case.
-
cf. In certain diesase types such as SKCM, days_to_death parameter is replaced with time_from_specimen_dx or time_from_specimen_procurement_to_death .
-
This analysis excluded clinical variables that has only NA values.
For survival clinical features, logrank test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values comparing quantile intervals using the 'coxph' function in R. Kaplan-Meier survival curves were plotted using quantile intervals at c(0, 0.25, 0.50, 0.75, 1). If there is only one interval group, it will not try survival analysis.
For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R
For two groups (mutant or wild-type) of continuous type of clinical data, wilcoxon rank sum test (Mann and Whitney, 1947) was applied to compare their mean difference using 'wilcox.test(continuous.clinical ~ as.factor(group), exact=FALSE)' function in R. This test is equivalent to the Mann-Whitney test.
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.